Nephrology2019-06-03T10:59:26+00:00

Nephrology Trials

Accelerating Nephrology Trials Globally

Within the past five years, nearly 30% of initiated or ongoing studies at Biorasi were those involving CKD subject populations. Biorasi has the experience to deliver Clinical Research Optimized™ in Nephrology clinical trials.

OVERCOMING COMPLEX TRIAL CHALLENGES

Biorasi delivers faster, higher quality trials in challenging renal indications by combining an industry-leading patient engagement program and a best-in-class data sciences department, all backed by a full-service global CRO for exceptional nephrology trial delivery.
Biorasi is an award-winning CRO accelerating nephrology clinical development for companies around the world.

Accelerating Nephrology Trials Globally

Biorasi delivers faster, higher quality trials in challenging renal indications by combining an industry-leading patient engagement program and a best-in-class data sciences department, all backed by a full-service global CRO for exceptional nephrology trial delivery. Biorasi provides sponsors with:

Nephrology Capabilities

Deep Understanding of Nephrology and the CKD Population

Biorasi has a long history of running successful trials in the chronic kidney disease space, and we’ve used that time to become true experts in nephrology clinical research. We’ve forged partnerships and connections with some of the top independent sites and site/LDO networks both within the United States, and abroad. We’ve built deep and lasting relationships with respected investigators. Our staff has trained extensively on managing and monitoring these uniquely challenging trials. In short, we are well set up to deliver Clinical Research Optimized™ in your nephrology trial.

Let us be part of your important work to find a solution to design your trial.

Contact Us Today

Related Resources

FSGS: A rare kidney disease without targeted therapies

By |Categories: Blog Articles|Tags: , |

Researchers are studying a few new and existing drugs to treat FSGS. FSGS needs a novel medication that regulates both high body fats and inflammasome inhibition via upstream innate immune system to block intracellular initiation of inflammatory cascade and extra cellular inflammation. Over the past five years, nearly 30% of Biorasi-initiated or ongoing studies involved chronic kidney disease. Our experience allows us to develop successful nephrology clinical trials.

Download our Precision Medicine Checklist

Complete the form below to receive a link to download this checklist
close-link

Schedule a call with one of our experts today

Let us know how we can help. Complete the form below and we will schedule a call
close-link

Start your FREE Trial Rescue Assessment!

Complete the form below and we will provide our free trial rescue assessment.
close-link

Download our Patient-Centric Trials White Paper

Complete the form below to receive a link to download this white paper
close-link

Download our Data Science White Paper

Complete the form below to receive a link to download this white paper
close-link

Schedule a TALOS™ Control Center Demo

Complete the form below to schedule a demo with our program development team
close-link

Download our Rare Disease Checklist

Complete the form below to receive a link to download this checklist
close-link

Download our Dermatology White Paper

Complete the form below to receive a link to download this white paper
close-link

Get Access to "Making Most of Trial Data" Webinar

Complete the form below to receive a link to access this webinar
close-link

Download our Precision Oncology White Paper

Complete the form below to receive a link to download this whitepaper
close-link